Description

Product Description:

Tirzepatide is a synthetic peptide designed as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It has been widely studied in preclinical and clinical research for its role in metabolic regulation and endocrine pathway signaling.

In research environments, Tirzepatide has been investigated for its interaction with incretin hormone systems, making it a valuable compound for examining glucose metabolism, receptor activation, and multi-pathway hormonal signaling.

Its dual-receptor mechanism distinguishes it from single agonists, and it is commonly utilized in experimental models focused on metabolic processes, peptide-receptor dynamics, and integrated endocrine function.

Key Features:

Chemical Name: Tirzepatide
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
CAS Number: 2023788-19-2
Amino Acid Sequence: Modified peptide analog (GLP-1/GIP receptor agonist)
Physical Form: Lyophilized powder
Compound Class: Synthetic peptide / Dual receptor agonist (GLP-1, GIP)
Purity: ≥98% (HPLC)
Storage Conditions: Store at 36–46°F (2–8°C) in a dry, light-protected environment.

Research References:

• Jastreboff, A. M. et al. (2023). Triple–hormone receptor agonist retatrutide for metabolic pathway research. New England Journal of Medicine.
• Coskun, T. et al. (2022). Multi-receptor peptide agonists and their role in metabolic signaling. Cell Metabolism.
• Eli Lilly and Company. (2023). Retatrutide (LY3437943) investigational studies in metabolic regulation.

(References provided for informational and research context only.)

Important Notice:

This product is intended for research use only. It is not for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. Use is restricted to qualified professionals in controlled laboratory environments.